In the EMPERIAL (Effect of EMPagliflozin on ExeRcise ability and HF symptoms In patients with chronic heArt faiLure) trial, SGLT2 inhibitors did not improve the 6-minute walking distance in patients with HF, including those with HFpEF.47 The gene discussed is SLC5A2; the disease is hydrops fetalis.